<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M287</article-id>
      <article-id pub-id-type="publisher-id">molbank-2002-M287</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ethyl 3-Chloropyrazine-2-carboxylate</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2002-M287">Institute of Pharmaceutical Chemistry, University of Vienna, Althanstra&#xDF;e 14, A-1090 Vienna, Austria; Tel. +43-1-4277-55124, Fax +43-1-4277-9551, E-mail: <underline><email>norbert.haider@univie.ac.at</email></underline></aff>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>02</month>
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2002</year>
      </pub-date>
      <volume>2002</volume>
      <issue>1</issue>
      <elocation-id>M287</elocation-id>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>05</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>05</month>
          <year>2002</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2002 MDPI.</copyright-statement>
        <copyright-year>2002</copyright-year>
        <license>
          <p>All rights reserved.</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>free-radical ethoxycarbonylation</kwd>
		<kwd>chloropyrazine</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2002-M287-i001.tif"/></p>
      <p>Free-radical alkoxycarbonylation of protonated pi-deficient hetarenes is a useful method for the introduction of ester functionalities into such systems [<xref ref-type="bibr" rid="B1-molbank-2002-M287">1</xref>], especially when the reaction is carried out in a two-phase solvent system in order to suppress polysubstitution [<xref ref-type="bibr" rid="B2-molbank-2002-M287">2</xref>]. Application of a protocol we recently used for analogous transformations of iodopyridazines into the corresponding esters, employing toluene as the organic phase [<xref ref-type="bibr" rid="B3-molbank-2002-M287">3</xref>], was found to provide a convenient access to the new title compound which represents a useful bifunctional building block.</p>
      <p>Thus, 3.4 g (30 mmol) of hydrogen peroxide (30%) were added dropwise between -10 and 0 &#xB0;C to 5.2 g (45 mmol) of ethyl pyruvate with stirring. The viscous liquid was kept at the same temperature for 15 min, then it was added dropwise to a vigorously stirred mixture of chloropyrazine (1.14 g, 10 mmol), water (7 ml), concentrated sulfuric acid (3.0 g, 30 mmol), ferrous sulfate heptahydrate (8.3 g, 30 mmol), and toluene (30 ml) at -5 to 0 &#xB0;C. Stirring was continued for another 15 min, then the mixture was poured into ice-water and it was extracted several times with dichloromethane. The combined extracts were washed with water, dried and evaporated. Excess ethyl pyruvate was removed by Kugelrohr distillation (30&#xB0;C, 1 mbar). The liquid residue [<xref ref-type="bibr" rid="B4-molbank-2002-M287">4</xref>] was purified by column chromatography on silica gel, eluting with ethyl acetate/light petroleum (1+3), followed by Kugelrohr distillation (110 &#xB0;C, 1 mbar) to afford the title compound as a colorless liquid (1.04 g, 56%). Storage in a refrigerator is recommended.</p>
      <p><underline><sup>1</sup>H NMR</underline> (300 MHz, CDCl<sub>3</sub>): 8.54-8.46 (AB system, J<sub>5-6</sub> = 2.5 Hz, 2 H, H-5, H-6), 4.45 (q, J = 7.1 Hz, 2 H, CH<sub>2</sub>), 1.39 (t, J = 7.1 Hz, 3 H, CH<sub>3</sub>).</p>
      <p><underline><sup>13</sup>C NMR</underline> (75 MHz, CDCl<sub>3</sub>): 163.2 (C=O), 147.2 (C-3), 145.3 (C-5), 144.7 (C-2), 141.7 (C-6), 62.6 (CH<sub>2</sub>), 13.9 (CH<sub>3</sub>).</p>
      <p><underline>IR</underline> (cm<sup>&#x2212;1</sup>; neat): 3055, 2984, 2939, 1735 (C=O), 1550, 1515, 1445, 1383, 1301, 1181, 1147, 1068, 1013, 857.</p>
      <p><underline>EI-MS</underline> (70 eV): 188 (1%, M<sup>+</sup>), 186 (3, M<sup>+</sup>), 144 (15), 142 (45), 141 (25), 116 (32), 114 (100), 113 (39), 86 (27), 79 (33), 62 (22), 52 (49), 51 (33).</p>
      <p>Anal. calc. for C<sub>7</sub>H<sub>7</sub>ClN<sub>2</sub>O<sub>2</sub> (186.60): C 45.06, H 3.78, N 15.01; found: C 45.4, H 3.6, N 14.6.</p>
  </body>
  <back>
    <app-group>
      <app id="app1-molbank-2002-M287">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2002-M287-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2002-M287-s001.jdx">
        <label>Supplementary File 1</label>
        </supplementary-material>
		<supplementary-material id="molbank-2002-M287-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2002-M287-s002.jdx">
		<label>Supplementary File 2</label>
        </supplementary-material>
		<supplementary-material id="molbank-2002-M287-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2002-M287-s003.jdx">
		<label>Supplementary File 3</label>
        </supplementary-material>
		<supplementary-material id="molbank-2002-M287-s004" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2002-M287-s004.jdx">
		<label>Supplementary File 4</label>
        </supplementary-material>
		<supplementary-material id="molbank-2002-M287-s005" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2002-M287-s005-mod.mol">
		<label>Supplementary File 5</label>
        </supplementary-material>
		<supplementary-material id="molbank-2002-M287-s006" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2002-M287-s005.mol">
		<label>Supplementary File 6</label>
        </supplementary-material>
	  </app>
    </app-group>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2002-M287">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minisci</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <source>Synthesis</source>
          <year>1973</year>
          <fpage>1</fpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2002-M287">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinisch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>L&#xF6;tsch</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron</source>
          <year>1985</year>
          <volume>41</volume>
          <fpage>1199</fpage>
        </citation>
      </ref>
      <ref id="B3-molbank-2002-M287">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>K&#xE4;ferb&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Heterocycles</source>
          <year>2000</year>
          <volume>53</volume>
          <fpage>2527</fpage>
        </citation>
      </ref>
      <ref id="B4-molbank-2002-M287">
        <label>4.</label>
          <note><p>According to HNMR, the crude material contains a smaller amount (approx. 13% of the main product) of the isomer, ethyl 5-chloropyrazine-2-carboxylate.</p></note>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p><italic>Sample availability</italic>: available from the author.</p>
      </fn>
    </fn-group>
  </back>
</article>